Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAI Pulse CheckAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastManufacturing IntelligenceShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers
Event Calendar

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Event Calendar
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Tamara T. Monesmith

Advertisement

Articles by Tamara T. Monesmith

i4-718864-1408622710387.jpg

Methods for the Automated Manufacturing of an Autologous Dendritic-Cell Immunotherapy

ByTamara T. Monesmith
May 1st 2011

The authors developed automated equipment that uses functionally closed disposables to perform cellular and ribonucleic processing.

Advertisement

Latest Updated Articles

  • i4-718864-1408622710387.jpg
    Methods for the Automated Manufacturing of an Autologous Dendritic-Cell Immunotherapy

    May 1st 2011



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Germany’s Medical Biotechnology Sector is Flourishing

2

MASH and Cardiomyopathy Targets: Why AstraZeneca Chose insitro’s AI

3

Formulation Strategies for Next-Generation Multiagonists

4

First-in-Human Trial Speed: Why FDA Trails China

5

PharmTech AI Pulse Check: Why Pharma Should Weigh In on FDA's Generative AI Paper

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us